tiprankstipranks
Positive Outlook for Stoke Therapeutics: Buy Rating Backed by Strong Leadership Transition, Robust Financial Position, and Promising Phase 3 Trial
PremiumRatingsPositive Outlook for Stoke Therapeutics: Buy Rating Backed by Strong Leadership Transition, Robust Financial Position, and Promising Phase 3 Trial
13d ago
Morning Movers: Sarepta slumps after death following Elevidys use
Premium
The Fly
Morning Movers: Sarepta slumps after death following Elevidys use
13d ago
Stoke Therapeutics Announces 2024 Financial Results and Updates
Premium
Company Announcements
Stoke Therapeutics Announces 2024 Financial Results and Updates
13d ago
Strategic Collaboration Between Stoke Therapeutics and Biogen Fuels Buy Rating for Zorevunersen Development
PremiumRatingsStrategic Collaboration Between Stoke Therapeutics and Biogen Fuels Buy Rating for Zorevunersen Development
1M ago
Strategic Collaboration with Biogen Boosts Stoke Therapeutics’ Financial and Market Position
Premium
Ratings
Strategic Collaboration with Biogen Boosts Stoke Therapeutics’ Financial and Market Position
1M ago
Strategic Collaboration and Positive Clinical Data Propel Stoke Therapeutics to a Buy Rating
Premium
Ratings
Strategic Collaboration and Positive Clinical Data Propel Stoke Therapeutics to a Buy Rating
1M ago
Stoke Therapeutics finalizes EMPEROR study program with regulatory agencies
PremiumThe FlyStoke Therapeutics finalizes EMPEROR study program with regulatory agencies
3M ago
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
Premium
Market News
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
3M ago
Stoke Therapeutics initiated with a Buy at Chardan
Premium
The Fly
Stoke Therapeutics initiated with a Buy at Chardan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100